JP2020114842A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020114842A5 JP2020114842A5 JP2020052658A JP2020052658A JP2020114842A5 JP 2020114842 A5 JP2020114842 A5 JP 2020114842A5 JP 2020052658 A JP2020052658 A JP 2020052658A JP 2020052658 A JP2020052658 A JP 2020052658A JP 2020114842 A5 JP2020114842 A5 JP 2020114842A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- organic solvent
- range
- cuprous
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 27
- 150000001875 compounds Chemical class 0.000 claims 23
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical group CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims 16
- 239000003960 organic solvent Substances 0.000 claims 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 10
- FXHOOIRPVKKKFG-UHFFFAOYSA-N DMA Chemical group CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims 9
- JVVRCYWZTJLJSG-UHFFFAOYSA-N 4-Dimethylaminophenol Substances CN(C)C1=CC=C(O)C=C1 JVVRCYWZTJLJSG-UHFFFAOYSA-N 0.000 claims 8
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 8
- SCVFZCLFOSHCOH-UHFFFAOYSA-M Potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 8
- 239000012190 activator Substances 0.000 claims 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 8
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 claims 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- -1 phenyl thionochlorolate Chemical group 0.000 claims 5
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims 4
- 235000011056 potassium acetate Nutrition 0.000 claims 4
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 4
- KXMMNJQMGILZDB-UHFFFAOYSA-N 1-(2-oxopyridine-1-carbothioyl)pyridin-2-one Chemical compound O=C1C=CC=CN1C(=S)N1C(=O)C=CC=C1 KXMMNJQMGILZDB-UHFFFAOYSA-N 0.000 claims 3
- NKNDPYCGAZPOFS-UHFFFAOYSA-M Copper(I) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 claims 3
- OXBLHERUFWYNTN-UHFFFAOYSA-M Copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims 3
- LSXDOTMGLUJQCM-UHFFFAOYSA-M Copper(I) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 claims 3
- RFKZUAOAYVHBOY-UHFFFAOYSA-M copper(1+);acetate Chemical compound [Cu+].CC([O-])=O RFKZUAOAYVHBOY-UHFFFAOYSA-M 0.000 claims 3
- 229940045803 cuprous chloride Drugs 0.000 claims 3
- 235000019439 ethyl acetate Nutrition 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 2
- QTMDXZNDVAMKGV-UHFFFAOYSA-L Copper(II) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 claims 2
- ZWZVWGITAAIFPS-UHFFFAOYSA-N Thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 claims 2
- MWPOEMYVTCIOPT-UHFFFAOYSA-M [O-]C(=S)OC1=CC=CC=N1 Chemical compound [O-]C(=S)OC1=CC=CC=N1 MWPOEMYVTCIOPT-UHFFFAOYSA-M 0.000 claims 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 2
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 claims 2
- 229910052802 copper Inorganic materials 0.000 claims 2
- 239000010949 copper Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 150000007530 organic bases Chemical class 0.000 claims 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 2
- SJRDNQOIQZOVQD-UHFFFAOYSA-M sodium;2,2-dimethylpropanoate Chemical compound [Na+].CC(C)(C)C([O-])=O SJRDNQOIQZOVQD-UHFFFAOYSA-M 0.000 claims 2
- KFYRJJBUHYILSO-YFKPBYRVSA-N (2S)-2-amino-3-dimethylarsanylsulfanyl-3-methylbutanoic acid Chemical compound C[As](C)SC(C)(C)[C@@H](N)C(O)=O KFYRJJBUHYILSO-YFKPBYRVSA-N 0.000 claims 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims 1
- KVNRLNFWIYMESJ-UHFFFAOYSA-N Butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 claims 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L Caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N Tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Inorganic materials [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 150000001879 copper Chemical class 0.000 claims 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N cu+ Chemical class [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N n-pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 150000002825 nitriles Chemical class 0.000 claims 1
- 239000001184 potassium carbonate Substances 0.000 claims 1
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 1
- 238000007363 ring formation reaction Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 0 C*(C)c(cc1)cc*1C(Oc1ccccc1)=N Chemical compound C*(C)c(cc1)cc*1C(Oc1ccccc1)=N 0.000 description 1
Claims (24)
- 前記チオカルボニル源が、O,O’−ジ(ピリジン−2−イル)カルボノチオエート、1,1’−チオカルボニルビス(ピリジン−2(1H)−オン)、ジ(1H−イミダゾール−1−イル)メタンチオン、チオホスゲン、アリールチオノクロロホルメート(アリールは、フェニル、ナフチル又はトリルである)又はチオカルボニルビス(ベンゾトリアゾール)である、請求項1に記載のプロセス。
- 前記活性化剤が、DMAP、NaH又はNaOHである、請求項1に記載のプロセス。
- 前記有機溶媒が、DMA、DMF、トルエン、DMSO、ACN、THF、DCM、EtOAc、アセトン、MEK又はジオキサンである、請求項1に記載のプロセス。
- 前記チオカルボニル源が、1,1’−チオカルボニルビス(ピリジン−2(1H)−オン)である、請求項1又は2に記載のプロセス。
- 前記活性化剤がDMAPである、請求項1〜5のいずれか一項に記載のプロセス。
- 前記有機溶媒がDMAである、請求項1〜6のいずれか一項に記載のプロセス。
- 前記チオカルボニル源がチオノクロロギ酸フェニルであり;前記活性化剤がDMAPであり;前記有機溶媒がDMAであり;前記温度が約−20℃〜約80℃の範囲である、請求項1に記載のプロセス。
- 前記チオカルボニル源がチオノクロロギ酸フェニルであり;前記活性化剤がDMAPであり;前記有機溶媒がアセトン又は酢酸エチルであり;前記温度が約−20℃〜約80℃の範囲である、請求項1に記載のプロセス。
- 環化直後にDMAPAが添加される、請求項9に記載のプロセス。
- 前記チオカルボニル源が、O,O’−ジ(ピリジン−2−イル)カルボノチオエート、1,1’−チオカルボニルビス(ピリジン−2(1H)−オン)、ジ(1H−イミダゾール−1−イル)メタンチオン、チオホスゲン、チオノクロロギ酸フェニル、O−(2−ナフチル)チオノクロロホルメート、トリルチオノクロロホルメート又はチオカルボニルビス(ベンゾトリアゾール)である、請求項12に記載のプロセス。
- 前記活性化剤が、DMAP、NaH又はNaOHである、請求項12又は14に記載のプロセス。
- ステップ(2f)における前記有機溶媒が、ジメチルアセトアミド、DMF、トルエン、DMSO、THF又はジオキサンである、請求項12〜15のいずれか一項に記載のプロセス。
- ステップ(2g)における前記有機溶媒が、THF、DMF、DMA、エタノール又はこれらの水性混合物である、請求項13〜16のいずれか一項に記載のプロセス。
- ステップ(2g)における前記有機溶媒が、エタノールである、請求項17に記載のプロセス。
- ステップ(2f)において、前記チオカルボニル源がチオノクロロギ酸フェニルであり、前記活性化剤がDMAPであり、前記有機溶媒がアセトン又は酢酸エチルであり、前記温度が、約−20℃〜40℃の範囲であり、
ステップ(2g)において、前記有機溶媒がエタノールである、請求項13に記載のプロセス。 - 化合物(2c−2B)が、
- 化合物(XIII)と式(2c−1)の化合物とを;臭化第一銅、TMEDAの存在下;酢酸カリウムの存在下;有機溶媒DMA中;80℃〜140℃の範囲の温度で反応させることを含む、請求項21に記載のプロセス。
- 化合物(XIII)と式(2c−1)の化合物とを;銅粉末又は銅スポンジである銅(0)源の存在下;酢酸カリウム又はピバル酸ナトリウムの存在下;有機溶媒DMSO中;0℃〜80℃の範囲の温度で反応させることを含む、請求項21に記載のプロセス。
- 化合物(XIII)と式(2c−1)の化合物とを;銅粉末又は銅スポンジである銅(0)源の存在下;酢酸カリウムの存在下;塩化第一銅、ヨウ化第一銅、臭化第一銅又は酢酸第一銅から選択される銅(I)塩を添加しつつ;有機溶媒DMSO中;0℃〜80℃の範囲の温度で反応させることを含む、請求項21に記載のプロセス。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462094436P | 2014-12-19 | 2014-12-19 | |
US62/094,436 | 2014-12-19 | ||
JP2017532725A JP6681902B2 (ja) | 2014-12-19 | 2015-12-17 | ジアリールチオヒダントイン化合物を調製するためのプロセス |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017532725A Division JP6681902B2 (ja) | 2014-12-19 | 2015-12-17 | ジアリールチオヒダントイン化合物を調製するためのプロセス |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2020114842A JP2020114842A (ja) | 2020-07-30 |
JP2020114842A5 true JP2020114842A5 (ja) | 2020-11-12 |
JP6903785B2 JP6903785B2 (ja) | 2021-07-14 |
Family
ID=55168400
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017532725A Active JP6681902B2 (ja) | 2014-12-19 | 2015-12-17 | ジアリールチオヒダントイン化合物を調製するためのプロセス |
JP2020052658A Active JP6903785B2 (ja) | 2014-12-19 | 2020-03-24 | ジアリールチオヒダントイン化合物を調製するためのプロセス |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017532725A Active JP6681902B2 (ja) | 2014-12-19 | 2015-12-17 | ジアリールチオヒダントイン化合物を調製するためのプロセス |
Country Status (33)
Country | Link |
---|---|
US (1) | US9688655B2 (ja) |
EP (4) | EP3372585B1 (ja) |
JP (2) | JP6681902B2 (ja) |
KR (1) | KR102586059B1 (ja) |
CN (1) | CN107108507A (ja) |
AR (1) | AR103228A1 (ja) |
AU (1) | AU2015364537B2 (ja) |
BR (1) | BR112017013113B1 (ja) |
CA (1) | CA2970937A1 (ja) |
CY (2) | CY1121684T1 (ja) |
DK (3) | DK3372585T3 (ja) |
EA (4) | EA201892485A1 (ja) |
ES (3) | ES2919951T3 (ja) |
HR (3) | HRP20220750T1 (ja) |
HU (2) | HUE052475T2 (ja) |
IL (1) | IL252843A0 (ja) |
LT (3) | LT3372584T (ja) |
MA (1) | MA41200B1 (ja) |
MD (1) | MD3233803T2 (ja) |
ME (1) | ME03420B (ja) |
MX (1) | MX2017008179A (ja) |
NZ (1) | NZ732766A (ja) |
PH (1) | PH12017501152A1 (ja) |
PL (3) | PL3372584T3 (ja) |
PT (3) | PT3372584T (ja) |
RS (3) | RS61060B9 (ja) |
SG (4) | SG10201912811QA (ja) |
SI (3) | SI3233803T1 (ja) |
TR (1) | TR201904739T4 (ja) |
TW (4) | TWI689494B (ja) |
UA (1) | UA123201C2 (ja) |
WO (1) | WO2016100652A2 (ja) |
ZA (1) | ZA201704877B (ja) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016100652A2 (en) * | 2014-12-19 | 2016-06-23 | Aragon Pharmaceuticals, Inc. | Process for the preparation of a diarylthiohydantoin compound |
HUE042349T2 (hu) | 2014-12-19 | 2019-06-28 | Aragon Pharmaceuticals Inc | Eljárás diariltiohidantoin vegyület elõállítására |
CN108069869B (zh) * | 2016-11-09 | 2022-03-01 | 上海医药工业研究院 | 一种Apalutamide的制备方法及其中间体 |
TW201831461A (zh) * | 2017-01-18 | 2018-09-01 | 台灣神隆股份有限公司 | 製備阿帕魯醯胺的方法 |
US10364245B2 (en) | 2017-06-07 | 2019-07-30 | Chiesi Farmaceutici S.P.A. | Kinase inhibitors |
CN107501237B (zh) * | 2017-08-17 | 2022-03-22 | 上海西浦医药科技有限公司 | 一种Apalutamide的合成方法 |
CN108383749B (zh) * | 2018-01-30 | 2021-03-09 | 杭州科巢生物科技有限公司 | 阿帕鲁胺的合成方法及其中间体 |
US10513504B2 (en) | 2018-03-08 | 2019-12-24 | Apotex Inc. | Processes for the preparation of apalutamide and intermediates thereof |
CN108314646B (zh) * | 2018-04-11 | 2021-03-19 | 武汉慧敏科技中心 | 一种高分散双金属纳米材料制备泌尿生殖系统用药物中间体的方法 |
CN109651256A (zh) * | 2018-11-20 | 2019-04-19 | 上海健康医学院 | 一种式(viii)的恩杂鲁胺的制备方法 |
CN110511207A (zh) * | 2019-06-17 | 2019-11-29 | 扬子江药业集团江苏海慈生物药业有限公司 | 芳基-2-硫代海因类化合物中间体、其制备方法及应用 |
CN110511206A (zh) * | 2019-06-17 | 2019-11-29 | 扬子江药业集团江苏海慈生物药业有限公司 | 芳基-2-硫代海因类化合物中间体、其制备方法及应用 |
WO2022049265A1 (en) | 2020-09-04 | 2022-03-10 | Synthon B.V. | Improved process for preparation of apalutamide |
CN113292535B (zh) * | 2021-06-18 | 2022-07-01 | 南京方生和医药科技有限公司 | 一种制备阿帕鲁胺中间体及阿帕鲁胺的方法 |
CN113402466B (zh) * | 2021-06-18 | 2022-08-16 | 南京方生和医药科技有限公司 | 一种阿帕鲁胺中间体及制备阿帕鲁胺的方法 |
CN115850233A (zh) * | 2021-09-24 | 2023-03-28 | 南京方生和医药科技有限公司 | 一种阿帕鲁胺的合成方法 |
CN115536634A (zh) * | 2022-10-17 | 2022-12-30 | 上海博悦生物科技有限公司 | 一种阿帕他胺的合成方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040077605A1 (en) | 2001-06-20 | 2004-04-22 | Salvati Mark E. | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
TWI263640B (en) * | 2001-12-19 | 2006-10-11 | Bristol Myers Squibb Co | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
EP3412290B1 (en) | 2006-03-27 | 2021-03-03 | The Regents of The University of California | Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
US8461343B2 (en) * | 2007-03-27 | 2013-06-11 | Sloan-Kettering Institute For Cancer Research | Synthesis of thiohydantoins |
BRPI0912802A2 (pt) * | 2008-05-16 | 2015-10-13 | Takeda San Diego Inc | ativadores de glicoquinase |
EA019970B8 (ru) * | 2009-12-11 | 2014-11-28 | Отифони Терапеутикс Лимитед | Производные имидазолидиндиона |
SI3124481T1 (en) * | 2010-02-16 | 2018-06-29 | Aragon Pharmaceuticals, Inc. | Androgen receptor modulators and their use |
BR112012021406B1 (pt) * | 2010-02-24 | 2021-08-10 | Medivation Prostate Therapeutics Llc | Processos para a síntese dos compostos de diariltioidantoína e diarilidantoína |
CN103608333B (zh) * | 2011-03-10 | 2016-01-06 | 苏州开拓药业有限公司 | 雄激素受体拮抗剂及其用途 |
WO2013029338A1 (en) * | 2011-09-01 | 2013-03-07 | Glaxo Group Limited | Novel compounds |
CN104379160A (zh) * | 2012-03-29 | 2015-02-25 | 桑加特公司 | 双阿司匹林交联聚乙二醇化血红蛋白 |
US9708289B2 (en) * | 2013-05-29 | 2017-07-18 | Hinova Pharmaceuticals Inc. | Imidazole diketone compound and use thereof |
WO2016100652A2 (en) * | 2014-12-19 | 2016-06-23 | Aragon Pharmaceuticals, Inc. | Process for the preparation of a diarylthiohydantoin compound |
-
2015
- 2015-12-17 WO PCT/US2015/066356 patent/WO2016100652A2/en active Application Filing
- 2015-12-17 RS RS20201378A patent/RS61060B9/sr unknown
- 2015-12-17 SG SG10201912811QA patent/SG10201912811QA/en unknown
- 2015-12-17 RS RS20220542A patent/RS63455B1/sr unknown
- 2015-12-17 HU HUE18169756A patent/HUE052475T2/hu unknown
- 2015-12-17 EA EA201892485A patent/EA201892485A1/ru unknown
- 2015-12-17 CN CN201580069602.5A patent/CN107108507A/zh active Pending
- 2015-12-17 SG SG10201912802XA patent/SG10201912802XA/en unknown
- 2015-12-17 SG SG10201912805SA patent/SG10201912805SA/en unknown
- 2015-12-17 DK DK18169895.2T patent/DK3372585T3/da active
- 2015-12-17 EP EP18169895.2A patent/EP3372585B1/en active Active
- 2015-12-17 NZ NZ732766A patent/NZ732766A/en unknown
- 2015-12-17 PL PL18169756T patent/PL3372584T3/pl unknown
- 2015-12-17 KR KR1020177019551A patent/KR102586059B1/ko active IP Right Grant
- 2015-12-17 EA EA201892487A patent/EA201892487A1/ru unknown
- 2015-12-17 HR HRP20220750TT patent/HRP20220750T1/hr unknown
- 2015-12-17 SI SI201530599T patent/SI3233803T1/sl unknown
- 2015-12-17 ME MEP-2019-86A patent/ME03420B/me unknown
- 2015-12-17 LT LTEP18169756.6T patent/LT3372584T/lt unknown
- 2015-12-17 PL PL18169895.2T patent/PL3372585T3/pl unknown
- 2015-12-17 MA MA41200A patent/MA41200B1/fr unknown
- 2015-12-17 US US14/973,089 patent/US9688655B2/en active Active
- 2015-12-17 EP EP18170050.1A patent/EP3372586A1/en not_active Withdrawn
- 2015-12-17 SI SI201531433T patent/SI3372584T1/sl unknown
- 2015-12-17 MX MX2017008179A patent/MX2017008179A/es active IP Right Grant
- 2015-12-17 JP JP2017532725A patent/JP6681902B2/ja active Active
- 2015-12-17 EA EA201791390A patent/EA201791390A1/ru unknown
- 2015-12-17 EP EP15823875.8A patent/EP3233803B1/en active Active
- 2015-12-17 ES ES18169895T patent/ES2919951T3/es active Active
- 2015-12-17 ES ES15823875T patent/ES2718539T3/es active Active
- 2015-12-17 DK DK15823875.8T patent/DK3233803T3/en active
- 2015-12-17 HU HUE15823875A patent/HUE042409T2/hu unknown
- 2015-12-17 CA CA2970937A patent/CA2970937A1/en active Pending
- 2015-12-17 ES ES18169756T patent/ES2827549T3/es active Active
- 2015-12-17 UA UAA201707588A patent/UA123201C2/uk unknown
- 2015-12-17 DK DK18169756.6T patent/DK3372584T5/da active
- 2015-12-17 PT PT181697566T patent/PT3372584T/pt unknown
- 2015-12-17 SI SI201531848T patent/SI3372585T1/sl unknown
- 2015-12-17 PT PT181698952T patent/PT3372585T/pt unknown
- 2015-12-17 LT LTEP18169895.2T patent/LT3372585T/lt unknown
- 2015-12-17 PT PT15823875T patent/PT3233803T/pt unknown
- 2015-12-17 MD MDE20170208T patent/MD3233803T2/ro unknown
- 2015-12-17 SG SG11201704969QA patent/SG11201704969QA/en unknown
- 2015-12-17 TR TR2019/04739T patent/TR201904739T4/tr unknown
- 2015-12-17 LT LTEP15823875.8T patent/LT3233803T/lt unknown
- 2015-12-17 EP EP18169756.6A patent/EP3372584B9/en active Active
- 2015-12-17 BR BR112017013113-7A patent/BR112017013113B1/pt active IP Right Grant
- 2015-12-17 RS RS20190350A patent/RS58454B1/sr unknown
- 2015-12-17 PL PL15823875T patent/PL3233803T3/pl unknown
- 2015-12-17 AU AU2015364537A patent/AU2015364537B2/en active Active
- 2015-12-17 EA EA201892486A patent/EA201892486A1/ru unknown
- 2015-12-18 TW TW108131623A patent/TWI689494B/zh active
- 2015-12-18 TW TW104142692A patent/TWI683810B/zh active
- 2015-12-18 TW TW108131622A patent/TWI703132B/zh active
- 2015-12-18 TW TW108146841A patent/TWI753336B/zh active
- 2015-12-21 AR ARP150104237A patent/AR103228A1/es unknown
-
2017
- 2017-06-12 IL IL252843A patent/IL252843A0/en unknown
- 2017-06-19 PH PH12017501152A patent/PH12017501152A1/en unknown
- 2017-07-18 ZA ZA2017/04877A patent/ZA201704877B/en unknown
-
2019
- 2019-03-19 HR HRP20190540TT patent/HRP20190540T1/hr unknown
- 2019-04-10 CY CY20191100400T patent/CY1121684T1/el unknown
-
2020
- 2020-03-24 JP JP2020052658A patent/JP6903785B2/ja active Active
- 2020-11-02 CY CY20201101031T patent/CY1123611T1/el unknown
- 2020-11-20 HR HRP20201847TT patent/HRP20201847T2/hr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2020114842A5 (ja) | ||
JP6903785B2 (ja) | ジアリールチオヒダントイン化合物を調製するためのプロセス | |
JP2019218396A (ja) | 5−フルオロ−4−イミノ−3−(アルキル/置換アルキル)−1−(アリールスルホニル)−3,4−ジヒドロピリミジン−2(1h)−オンおよびそれらの調製方法 | |
JP2017122107A5 (ja) | ||
JP2007523139A5 (ja) | ||
JP2018535262A (ja) | 4−((6−(2−(2,4−ジフルオロフェニル)−1,1−ジフルオロ−2−オキソエチル)ピリジン−3−イル)オキシ)ベンゾニトリル及び製造方法 | |
JP2010513494A5 (ja) | ||
JP2023116769A5 (ja) | ||
WO2018094147A1 (en) | 4-((6-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-mercapto-1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation | |
TWI832015B (zh) | 酪胺酸激酶抑制物之合成 | |
WO2012088776A1 (zh) | 2-(n-取代)-氨基苯并咪唑衍生物的制备方法 | |
JP2018502081A5 (ja) | ||
BR112019009793A2 (pt) | 4-((6-(2-(2,4-difluorofenil)-1,1-difluoro-2-hidróxi-3-(5-mercapto-1h-1,2,4-triazol-1-il)propil)piridin-3-il)óxi)benzonitrila e processos de preparação | |
US11466014B2 (en) | Process for preparing soluble guanylate cyclase stimulators | |
EP3555047A1 (en) | T-butyl 2-carbamothioyl-2-(3-(5-(4-cyanophenoxy)pyridin-2-yl)-2-(2,4- difluorophenyl)-3,3-difluoro-2-hydroxypropyl)hydrazine-1-carboxylate and processes of preparation | |
JP6009851B2 (ja) | 1h−テトラゾール誘導体の製造方法 | |
JP2018529703A5 (ja) | ||
JP4575666B2 (ja) | 2−シアノアジリジン−1−カルボキサミドの合成 | |
Yang et al. | Facile Synthesis of 1-(4-Bromophenyl)-1 H-Tetrazol-5-Amine and Related Amide Derivatives | |
RU2615630C1 (ru) | Ониевые соли 4-(1,1-динитроэтил-1-ONN-азокси)-3-(1Н-тетразол-5-ил)фуроксана и способы их получения | |
TW200918504A (en) | Nicotinamide-derivatives and process for their production | |
JPH0152386B2 (ja) | ||
JP5892605B2 (ja) | 4−(2−チエニル)イミダゾール化合物 | |
RU2003130073A (ru) | Способ получения циталопрама | |
JPH1045724A (ja) | N−スルホニルピリミジンカルボン酸アミド誘導体の製造法 |